<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A population-based case-control study of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was conducted in the San Francisco Bay Area of California from 1988 to 1995 </plain></SENT>
<SENT sid="1" pm="."><plain>The study used Working Formulation histologic subtypes of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Diffuse and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> large-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and <z:hpo ids='HP_0000001'>all</z:hpo> follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were combined to reflect two Revised European-American <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> (REAL) classifications </plain></SENT>
<SENT sid="3" pm="."><plain>Results were obtained from age- and sex-adjusted polytomous multivariable logistic models for 1,304 cases and 2,402 controls who were negative for human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus </plain></SENT>
<SENT sid="4" pm="."><plain>Statistically significant odds ratios for REAL large-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were decreased for receipt of five or more different vaccines (odds ratio (OR) = 0.65), use of <z:chebi fb="0" ids="38215">calcium channel blockers</z:chebi> (OR = 0.35), <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">mononucleosis</z:e> (OR = 0.55), plant <z:e sem="disease" ids="C0869403,C0700625,C0020517" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">allergies</z:e> (OR = 0.72), and animal <z:e sem="disease" ids="C0869403,C0700625,C0020517" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">allergies</z:e> (OR = 0.40) </plain></SENT>
<SENT sid="5" pm="."><plain>Odds ratios for REAL follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were decreased for use of <z:chebi fb="2" ids="35475">nonsteroidal antiinflammatory drugs</z:chebi> (OR = 0.67), <z:hpo ids='HP_0012115'>hepatitis</z:hpo> (OR = 0.36), and having had three or more bee or wasp stings (OR = 0.79) and were increased for <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> (OR = 1.5) </plain></SENT>
<SENT sid="6" pm="."><plain>Similar elevated odds ratios for <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">heart disease</z:e> and Bacillus Calmette-Gu√©rin vaccine and decreased odds ratios for <z:chebi fb="2" ids="35475">nonsteroidal antiinflammatory drugs</z:chebi>, plant <z:e sem="disease" ids="C0869403,C0700625,C0020517" disease_type="Pathologic Function;Disease or Syndrome" abbrv="">allergies</z:e>, and three or more bee or wasp stings were found for small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>These data provide direction for further investigation of immune function and genetic characteristics of subtypes of non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> and warrant analyses in large pooled data sets </plain></SENT>
</text></document>